The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Elevated plasma levels of exosomal BACE1‑AS combined with the volume and thickness of the right entorhinal cortex may serve as a biomarker for the detection of Alzheimer's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The lncRNA species BACE1-AS strongly correlates with BACE1 expression and is measurable in human plasma samples, with levels increased in patients with AD and autism.
“The lncRNA species BACE1‐AS strongly correlates with BACE1 expression and is also measurable in human plasma samples, with levels increased in patients with AD 193 and autism.”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [193]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Pegtel, D. M., & Gould, S. J. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111902 · Cited by 2,682
Fiandaca, M. S., Kapogiannis, D., Mapstone, M., Boxer, A., Eitan, E., Schwartz, J. B., Abner, E. L., Petersen, R. C., Federoff, H. J., Miller, B. L., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.06.008 · Cited by 959
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
Hampel, H., O’Bryant, S. E., Molinuevo, J. L., Zetterberg, H., Masters, C. L., Lista, S., Kiddle, S. J., Batrla, R., & Blennow, K. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0079-7 · Cited by 716
Anstey, K. J., Ashby-Mitchell, K., & Peters, R. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160826 · Cited by 360
The Transport Mechanism of Extracellular Vesicles at the Blood-Brain Barrier
Matsumoto, J., Stewart, T., Banks, W. A., & Zhang, J. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612823666170913164738 · Cited by 267 · cited 2×
“due to their small size, exosomes can pass through the blood-brain barrier (BBB) freely (11-13).”
BackgroundFDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: A longitudinal study
Initiative, O. B. O. A. D. N., Ou, Y.-N., Xu, W., Li, J.-Q., Guo, Y., Cui, M., Chen, K.-L., Huang, Y.-Y., Dong, Q., Tan, L., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0512-1 · Cited by 155
Zhao, W., Wang, X., Yin, C., He, M., Li, S., & Han, Y. (2019) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2019.00013 · Cited by 145
Remote control of BBB: A tale of exosomes and microRNA
Zhao, Z., & Zlokovic, B. V. (2017) · Cell Research · doi:10.1038/cr.2017.71 · Cited by 70
Flagged first, then by citations
Research works printed but not linked: 47
- Bianchi, 2019, Effect of nutrition on neurodegenerative diseases. A systematic review, Nutr Neurosci, 4, 1, 10.1080/1028415X.2019.1681088 · DOI
- Arvanitakis, 2019, Diagnosis and management of dementia: Review, JAMA, 322, 1589, 10.1001/jama.2019.4782 · DOI
- Smedinga, 2018, Ethical arguments concerning the use of Alzheimer's disease biomarkers in individuals with no or mild cognitive impairment: A systematic review and framework for discussion, J Alzheimers Dis, 66, 1309, 10.3233/JAD-180638 · DOI
- Molinuevo, 2018, Current state of Alzheimer's fluid biomarkers, Acta Neuropathol, 136, 821, 10.1007/s00401-018-1932-x · DOI · Paper page
- Li, 2018, Systematic analysis and biomarker study for Alzheimer's disease, Sci Rep, 8, 17394, 10.1038/s41598-018-35789-3 · DOI
- Gleerup, 2019, Biomarkers for Alzheimer's disease in saliva: A systematic review, Dis Markers, 2019, 4761054, 10.1155/2019/4761054 · DOI
- Quek, 2017, The role of extracellular vesicles in neurodegenerative diseases, Biochem Biophys Res Commun, 483, 1178, 10.1016/j.bbrc.2016.09.090 · DOI · Paper page
- Liu, 2019, Role of exosomes in central nervous system diseases, Front Mol Neurosci, 12, 240, 10.3389/fnmol.2019.00240 · DOI
- Yoo, 2018, Toward exosome-based neuronal diagnostic devices, Micromachines (Basel), 9, E634, 10.3390/mi9120634 · DOI
- Si, 2019, Central nervous system-derived exosomal alpha-synuclein in serum may be a biomarker in Parkinson's disease, Neuroscience, 413, 308, 10.1016/j.neuroscience.2019.05.015 · DOI
- Hartmann, 2017, Exosomes and the prion protein: More than one truth, Front Neurosci, 11, 194, 10.3389/fnins.2017.00194 · DOI
- Yang, 2018, The serum exosome derived MicroRNA-135a, −193b, and −384 were potential Alzheimer's disease biomarkers, Biomed Environ Sci, 31, 87
- Bellingham, 2012, Exosomes: Vehicles for the transfer of toxic proteins associated with neurodegenerative diseases, Front Physiol, 3, 124, 10.3389/fphys.2012.00124 · DOI · Paper page
- Cortini, 2019, Emerging roles of long non-coding RNAs in the pathogenesis of Alzheimer's disease, Ageing Res Rev, 50, 19, 10.1016/j.arr.2019.01.001 · DOI
- Luo, 2016, Long noncoding RNAs and Alzheimer's disease, Clin Interv Aging, 11, 867, 10.2147/CIA.S107037 · DOI
- Faghihi, 2008, Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase, Nat Med, 14, 723, 10.1038/nm1784 · DOI · Paper page
- Ciarlo, 2013, An intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is upregulated in post-mortem Alzheimer's disease brain samples, Dis Model Mech, 6, 424, 10.1242/dmm.009761 · DOI
- Mus, 2007, Dendritic BC200 RNA in aging and in Alzheimer's disease, Proc Natl Acad Sci USA, 104, 10679, 10.1073/pnas.0701532104 · DOI
- McKhann, 2011, The diagnosis of dementia due to Alzheimer's disease: Recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, 7, 263, 10.1016/j.jalz.2011.03.005 · DOI · Paper page
- Calvini, 2009, Automatic analysis of medial temporal lobe atrophy from structural MRIs for the early assessment of Alzheimer disease, Med Phys, 36, 3737, 10.1118/1.3171686 · DOI
- Menéndez-González, 2015, Structural neuroimaging of the medial temporal lobe in Alzheimer's disease clinical trials, J Alzheimers Dis, 48, 581, 10.3233/JAD-150226 · DOI
- Juottonen, 1999, Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease, AJNR Am J Neuroradiol, 20, 139
- Pennanen, 2004, Hippocampus and entorhinal cortex in mild cognitive impairment and early AD, Neurobiol Aging, 25, 303, 10.1016/S0197-4580(03)00084-8 · DOI
- Kantarci, 2005, Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease, Expert Rev Neurother, 5, 663, 10.1586/14737175.5.5.663 · DOI
- Yu, 2012, The Beijing version of the montreal cognitive assessment as a brief screening tool for mild cognitive impairment: A community-based study, BMC Psychiatry, 12, 156, 10.1186/1471-244X-12-156 · DOI
- Lu, 2011, Montreal cognitive assessment in detecting cognitive impairment in Chinese elderly individuals: A population-based study, J Geriatr Psychiatry Neurol, 24, 184, 10.1177/0891988711422528 · DOI
- Yang, 2016, Optimal cutoff scores for Alzheimer's disease using the Chinese version of mini-mental state examination among Chinese population living in rural areas, Am J Alzheimers Dis Other Demen, 31, 650, 10.1177/1533317516662336 · DOI
- Morris, 1993, The clinical dementia rating (CDR): Current version and scoring rules, Neurology, 43, 2412, 10.1212/WNL.43.11.2412-a · DOI · Paper page
- Juva, 1994, Staging the severity of dementia: Comparison of clinical (CDR, DSM-III-R), functional (ADL, IADL) and cognitive (MMSE) scales, Acta Neurol Scand, 90, 293, 10.1111/j.1600-0404.1994.tb02724.x · DOI
- Mulsant, 1994, The use of the hamilton rating scale for depression in elderly patients with cognitive impairment and physical Illness, Am J Geriatr Psychiatry, 2, 220, 10.1097/00019442-199400230-00006 · DOI
- Zhang, 2019, Exosomes secreted by endothelial progenitor cells improve the bioactivity of pulmonary microvascular endothelial cells exposed to hyperoxia in vitro, Ann Transl Med, 7, 254, 10.21037/atm.2019.05.10 · DOI
- Pua, 2019, Increased hematopoietic extracellular RNAs and vesicles in the lung during allergic airway responses, Cell Rep, 26, 933, 10.1016/j.celrep.2019.01.002 · DOI
- Hannafon, 2016, Plasma exosome microRNAs are indicative of breast cancer, Breast Cancer Res, 18, 90, 10.1186/s13058-016-0753-x · DOI
- Bachurski, 2019, Extracellular vesicle measurements with nanoparticle tracking analysis-an accuracy and repeatability comparison between NanoSight NS300 and ZetaView, J Extracell Vesicles, 8, 1596016, 10.1080/20013078.2019.1596016 · DOI
- Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method, Methods, 25, 402, 10.1006/meth.2001.1262 · DOI · Paper page
- Yang, 2013, Discrimination between Alzheimer's disease and mild cognitive impairment using SOM and PSO-SVM, Comput Math Methods Med, 2013, 253670, 10.1155/2013/253670 · DOI
- Pagnozzi, 2019, Quantifying deep grey matter atrophy using automated segmentation approaches: A systematic review of structural MRI studies, Neuroimage, 201, 116018, 10.1016/j.neuroimage.2019.116018 · DOI
- Allison, 2019, Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum, Neuroimage Clin, 23, 101895, 10.1016/j.nicl.2019.101895 · DOI
- Olsson, 2016, CSF and blood biomarkers for the diagnosis of Alzheimer's disease: A systematic review and meta-analysis, Lancet Neurol, 15, 673, 10.1016/S1474-4422(16)00070-3 · DOI · Paper page
- Jia, 2019, Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid, Alzheimers Dement, 15, 1071, 10.1016/j.jalz.2019.05.002 · DOI
- Li, 2019, The effect of BACE1-AS on β-amyloid generation by regulating BACE1 mRNA expression, BMC Mol Biol, 20, 23, 10.1186/s12867-019-0140-0 · DOI · Paper page
- Feng, 2018, Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease, BMC Neurol, 18, 4, 10.1186/s12883-017-1008-x · DOI
- Fotuhi, 2019, Long non-coding RNA BACE1-AS may serve as an Alzheimer's disease blood-based biomarker, J Mol Neurosci, 69, 351, 10.1007/s12031-019-01364-2 · DOI
- Espinosa Del Pozo, 2018, Cognitive decline in adults aged 65 and older in cumbayá, quito, ecuador: Prevalence and risk factors, Cureus, 10, e3269
- Kimura, 2019, Malnutrition is associated with behavioral and psychiatric symptoms of dementia in older women with mild cognitive impairment and early-stage Alzheimer's disease, Nutrients, 11, E1951, 10.3390/nu11081951 · DOI
- Doorduijn, 2019, Energy and protein intake of Alzheimer's disease patients compared to cognitively normal controls: Systematic review, J Am Med Dir Assoc, 20, 14, 10.1016/j.jamda.2018.06.019 · DOI
- Wolters, 2019, Hemoglobin and anemia in relation to dementia risk and accompanying changes on brain MRI, Neurology, 93, e917, 10.1212/WNL.0000000000008003 · DOI
Cited by
Sorted by citations
Long Non-Coding RNA (lncRNA) Roles in Cell Biology, Neurodevelopment and Neurological Disorders
Aliperti, V., Skonieczna, J., & Cerase, A. (2021) · Non-Coding RNA · doi:10.3390/ncrna7020036 · Cited by 137
BACE1: More than just a β‐secretase
Taylor, H. A., Przemylska, L., Clavane, E. M., & Meakin, P. J. (2022) · Obesity Reviews · doi:10.1111/obr.13430 · Cited by 107
Monteiro-Reis, S., Carvalho-Maia, C., Bart, G., Vainio, S. J., Pedro, J., Silva, E. R., Sales, G., Henrique, R., & Jerónimo, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063267 · Cited by 21
Metadata
- Authors
- Wang, D., Wang, P., Bian, X., Xu, S., Zhou, Q., Zhang, Y., Ding, M., Han, M., Huang, L., Bi, J., Jia, Y., & Xie, Z.
- Affiliations
- Department of Neurology, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China
- Center of Evidence‑Based Medicine, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China
- Department of Geriatrics, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China
- Department of Radiology, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China
- Institute of Medical Sciences, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China
- Venue
- Molecular Medicine Reports
- Publisher
- Spandidos Publications
- Published
- 2020-05-05
- Volume
- 22
- Issue
- 1
- Pages
- 227-238
- ISSN
- 1791-2997
- 1791-3004
- PMC
- PMC7248487
- Cited by
- 65
- References
- 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review